Assessment of EF192A Potential Sensitization and Accumulated and Primary Irritability in Controlled/Maximized Conditions

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

January 20, 2025

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Skin LesionSkin LesionsSkin Care
Interventions
DEVICE

EF192A

EF192A will be applied through a patch test to the participants' backs for 3 consecutive weeks, with 3 weekly applications. Afterwards, there will be a rest period of between 10 and 15 days. EF192A will be reapplied to the participants' back in a naive area and removed after 48 hours.

DEVICE

Saline solution

The saline solution will be applied via patch test to the participants' backs for 3 consecutive weeks, with 3 weekly applications. Afterwards, there will be a rest period of between 10 and 15 days. The saline solution will be applied again to the participants' back in a naive area and removed after 48 hours.

Trial Locations (1)

06696-000

Eurofarma Laboratórios S.A, Itapevi

Sponsors
All Listed Sponsors
lead

Eurofarma Laboratorios S.A.

INDUSTRY

NCT06731062 - Assessment of EF192A Potential Sensitization and Accumulated and Primary Irritability in Controlled/Maximized Conditions | Biotech Hunter | Biotech Hunter